National Institutes of Health (NIH) — Full Portfolio
2,639 tracked investments · page 14 of 14 · listed companies and verified rows first
Xoran develops point-of-care CT imaging systems and related software for hospitals, clinics, and veterinary practices.
AI & Machine LearningHardwareHealthtechMedical DevicesAnn Arbor, US
XPose Therapeutics is a drug discovery company using structure-based approaches to identify small molecule and biotherapeutic candidates across oncology, immunology, and other therapeutic areas.
AI & Machine LearningBiotechDeep TechHealthtechSan Francisco, US
Debanu Das(Co-Founder & CEO)Ashley Deacon(Co-Founder & VP Structural Biology)Matthew Duncton(Co-Founder & VP Medicinal Chemistry)Millie Georgiadis(Co-Founder)
XyloCor Therapeutics develops gene therapies for advanced coronary artery disease and cardiac damage.
BiotechHealthtechMedical DevicesMalvern, US
Ronald Crystal(Founder and Advisor (Board Observer))Todd Rosengart(Founder; Board Observer)John Tucker(President and CEO)Albert Gianchetti(Executive Officer, Director)
BoardGlenn Batchelder(Director)inJames Cohen(Director)
Co-investorsLumira VenturesFountain Healthcare PartnersJeito CapitalLongwood FundSofinnova Ventures
XYLYX develops transplantation technologies using regenerative medicine, bioengineering, and translational science to expand access to organ transplantation.
BiotechHealthtechMedical DevicesNew York, US
John O'Neill(Chief Scientific Officer, Co-Founder, Board Director)in
Co-investorsBoston Harbor Angels
Yali develops fermentation technology to produce sustainable fats and lipids for alternative dairy products like ice cream, butter, and milk, using fewer inputs than conventional sources.
BiotechCleantechClimate TechFoodTech
Co-investorsFirst In VenturesFTW VenturesS2G InvestmentsCRCM VenturesThird Kind Venture Capital
Yasa Therapeutics develops PPCM, a nanoscale polymer technology platform designed for contraception and anti-infective applications including viral and bacterial prevention.
BiotechFemTechHealthtechMedical Devices
Mary Weitzel(Co-Founder, CEO, President)Barbara North(Co-founder, Chief Medical Officer)Michael Oldham(Co-Founder, Regulatory Advisor, Pre-clinical development expert)
Yenos Analytical develops microRNA-based liquid biopsy tests for early detection of multiple cancer types using urine samples.
BiotechDigital HealthHealthtechMedical DevicesEl Dorado Hills, US
Distinguished retired Professor from the University of California at Santa Cruz
Zansors develops sensor devices and mobile applications to monitor health biomarkers like heart rate and breathing patterns, enabling patients to detect early warning signs of conditions such as heart disease and sleep disorders.
Digital HealthHealthtechIoTMedical Devices
ZBeats is a cardiac technology company offering FDA-cleared electrocardiographic analysis software that transforms ECG signals into structured clinical intelligence for cardiology workflows.
AI & Machine LearningHealthtechMedical Devices
Co-investorsCamellia Venture Capital
Fayetteville, US
Michael Artinger(Executive Officer, Director)Bernie Prusaczyk(Executive Officer)Masoud Agah(Director)
BoardRobert Calvin Goforth(Director)
BiotechConcord, US
Ronald M. Lindsay(Executive Officer, Director)inRichard A. Lerner(Director)
BoardPhillip Frost(Director)
Zenflow develops medical devices for treating benign prostatic hyperplasia (BPH) in men, founded from the Stanford Byers Center for Biodesign with a team experienced in medical device development and FDA regulation.
HealthtechMedical DevicesSan Francisco, US
Shreya Mehta(CTO)inNick Damiano(CEO)inJohn Beck(Executive Officer)in
BoardBryan Kim(Director)Robert Weisskoff(Director)inBlayne Roeder(Director)
Co-investorsAstiaCloudStone CapitalDorm RoomF-Prime CapitalShangBay Capital LLCY Combinator+16 more
Zetagen is a biotechnology company focused on bone-related disease, developing small-molecule therapeutics and approaches targeting bone tumor progression, stem cell activity to promote bone formation, and cancers such as Ewing's sarcoma.
BiotechHealthtechMedical DevicesSyracuse, US
Joe C Loy(Executive Officer, Director)Peter B. Finn(Executive Officer)Nikhil Thakur, MD(Executive Officer, Director)David Tischler(Executive Officer, Director)
BoardRichard Warburg(Director)Ashok Kaveeshwar(Director)
Co-investorsJStar Capital Investments
Zeteo Tech develops mass spectrometry and detection technologies for biomedical, defense, and security applications, including bioaerosol detection and breath analysis.
BiotechDeep TechDefense TechMedical DevicesSykesville, US
Charles J. Call(Executive Officer, Director)inWayne Bryden(President and CEO)inTom McCreery(VP, Innovation / Chief Innovation Officer)inMike McLoughlin(VP, Research / Chief Technology Officer)Susan Furney(Chief Operating Officer)Jerry Carlisle(Chief Financial Officer)
Co-investorsAnzu PartnersCottonwood Technology Fund
Ziteo Medical is developing a handheld, miniaturized intraoperative molecular imaging device that combines molecular imaging, computer vision, and augmented reality to help surgeons locate and remove cancerous tissue.
AI & Machine LearningHealthtechMedical DevicesBerkeley, US
ZoneOne Pharma develops liposomal medicines for chronic disorders, leveraging proprietary delivery technologies to improve dosing and patient compliance compared to existing therapies.
BiotechHealthtechMedical Devices
Francis C. Szoka(Co-Founder, Chairman of the Board)Charles O. Noble(Founding Scientist, President)
ZRT Laboratory provides at-home hormone and wellness testing using saliva and dried blood spot methods for individuals, healthcare providers, and research teams.
Digital HealthHealthtechWellness & Fitness
BiotechPhiladelphia, US
Daniel Mazzucco(Executive Officer, Director)Rugart Eric(Executive Officer, Director)
BoardLouis Berardi(Director)
Co-investorsBen Franklin Technology PartnersBroad Street AngelsRowan Innovation Venture Fund
Zylö Therapeutics develops therapeutic delivery technology, focusing on product development in the biotech and drug-delivery space.
BiotechHealthtechGreenville, US
Scott R. Pancoast(CEO & Founder)inCharles E. Hinkle(Chief Financial Officer)inAndrew Draganski(Vice President, Product Development)Thomas Patrick Murray(Executive Officer)Lance Michael White(Director)Gary J Atkinson(Director)
Co-investorsAEON FoundryArieal Southeast Angel PartnersBoston Harbor AngelsCowtown AngelsHBS Angels of Boston
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
ZIVA CORPORATION
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.


































